Severe deficiency of the
von Willebrand factor (
VWF)-cleaving protease ADAMTS13 can lead to
thrombotic thrombocytopenic purpura (
TTP), a disease associated with the widespread formation of platelet-rich thrombi in many organs.
Autoantibodies that inactivate ADAMTS13 are the most frequent cause of acquired
TTP. Little is known about
epitope specificity and reactivity of anti-ADAMTS13
antibodies. In this study, a series of ADAMTS13 domains were expressed in Escherichia coli, and the reactivity of purified recombinant fragments with anti-ADAMTS13 auto-
antibodies from 25 patients with severe ADAMTS13 deficiency was evaluated in vitro. All
TTP plasmas contained
antibodies directed against the
cysteine-rich spacer (cys-rich/spacer) domain of ADAMTS13. In the plasma of 3 patients,
antibodies were detected that reacted exclusively with the cys-rich/spacer domain, underscoring the importance of this region for functional activity of ADAMTS13. In 64% of the plasmas,
antibodies reacted with the 2 CUB domains, and in 56% they reacted with the isolated first
thrombospondin type 1 (TSP-1) repeat and with the compound fragment consisting of the catalytic, the
disintegrin-like, and the TSP1-1 domain. Less frequently, in 28% of the plasmas,
antibodies reacted with the TSP1 repeats 2 to 8. Unexpectedly,
antibodies reacted with the propeptide region in 20% of the plasmas. In conclusion, this study shows that even though anti-ADAMTS13
autoantibodies react with multiple domains of the
protease, the cys-rich/spacer domain is consistently involved in antibody reactivity.